Stock ALQGC QUANTUM GENOMICS
Add to a list
To use this feature you must be a member
Log inSign up

Quantum Genomics Share Price

Equities

ALQGC

FR0011648971

Biotechnology & Medical Research

Market Closed - Euronext Paris
Other stock markets
 08:55:15 26/04/2024 pm IST 		5-day change 1st Jan Change
0.1292 EUR +1.89% Intraday chart for Quantum Genomics +9.86% +21.89%
13/03 Quantum Genomics Société Anonyme Reports Earnings Results for the Full Year Ended December 31, 2023 CI
2023 Quantum Genomics Société Anonyme Reports Earnings Results for the Half Year Ended June 30, 2023 CI

Financials

Sales 2024 * - Sales 2025 * - Capitalization 4.5M 4.81M 402M
Net income 2024 * -3M -3.21M -268M Net income 2025 * - EV / Sales 2024 * -
Net cash position 2024 * 8.7M 9.3M 776M Net cash position 2025 * - 0 0 EV / Sales 2025 * -
P/E ratio 2024 *
-1.44 x
P/E ratio 2025 *
-
Employees 3
Yield 2024 *
-
Yield 2025 *
-
Free-Float 87.23%
More Fundamentals * Assessed data

Chart Quantum Genomics

Dynamic Chart

Latest news about Quantum Genomics

Quantum Genomics Société Anonyme Reports Earnings Results for the Full Year Ended December 31, 2023 CI
Quantum Genomics Société Anonyme Reports Earnings Results for the Half Year Ended June 30, 2023 CI
Quantum Genomics: negotiations with Vistacare terminated CF
Global markets live: Microsoft, Raytheon, JPMorgan, Credit Suisse... Our Logo
Quantum Genomics Société Anonyme Reports Earnings Results for the Full Year Ended December 31, 2022 CI
Quantum Genomics: advanced discussions with a partner CF
Quantum Genomics Ousts Board President; CEO Named Successor MT
Quantum Genomics' Hypertension Drug Firibastat Fails to Show Significant Efficacy in Late-Stage Trial MT
Quantum Genomics Announces Lack of Significant Efficacy for Firibastat in Their Phase III Study, Fresh and Is Redirecting to New Developments CI
Certain Shares of Quantum Genomics Société Anonyme are subject to a Lock-Up Agreement Ending on 24-OCT-2022. CI
Quantum Genomics Société Anonyme Reports Earnings Results for the Half Year Ended June 30, 2022 CI
Quantum Genomics Société Anonyme(ENXTPA:ALQGC) dropped from S&P Global BMI Index CI
Quantum Genomics Announces the Appointment of Its New Scientific Advisory Board CI
Quantum Genomics Announces the End of Patient Recruitment for its Phase III Pivotal Study FRESH CI
Quantum Genomics Appoints Sarah Merlen Boulenger as Head of Regulatory Affairs CI
More news

Analyst Recommendations on Quantum Genomics

Quantum Genomics : Bryan Garnier and Co Initiates the Coverage of Quantum Genomics with a Target Price at 13 EUR per Share AT
Bryan Garnier & Co Initiates the Coverage of Quantum Genomics with a Target Price at 13€ per Share AQ
More recommendations

Press releases Quantum Genomics

Quantum Genomics : Quantum Genomics announces that it has obtained the approval of Shareholders on the reduction of its share capital and on the contribution in kind of 100% of ExactCure’s securities. AT
Quantum Genomics : Quantum Genomics publishes its results for the 2023 financial year. The merger with ExactCure, which marks the strategic redeployment of the company and will be submiCed for a shareholder vote on April 24. AT
Quantum Genomics : Quantum Genomics enters into exclusive negotiations with ExactCure AT
Quantum Genomics : Quantum Genomics Releases First-Half 2023 Financial Results AT
Quantum Genomics : Quantum Genomics announces resuming discussions with HealthTech companies following the termination of exclusive negotiations with Vistacare Medical AT
More press releases

News in other languages on Quantum Genomics

Quantum Genomics : Quantum Genomics annonce avoir obtenu l’approbation de l’Assemblée Générale des Actionnaires sur la réduction de son capital social et sur l’apport en nature de 100% des titres d’ExactCure.
Stop ou encore ?
Assystem : Engie, Saint-Gobain, Technip Energies... les valeurs à suivre aujourd'hui à la Bourse de Paris
En direct des Marchés : Engie, GTT, Technip Energies, BioMérieux, AB Inbev, Nestlé, ID Logistics...
Bolsa de Madrid: ¿Parar o continuar?
More news

Quotes and Performance

1 day+1.89%
1 week+9.86%
Current month+20.30%
1 month+25.93%
3 months+13.33%
6 months+43.56%
Current year+21.89%
More quotes

Highs and lows

1 week
0.11
Extreme 0.1108
0.14
1 month
0.10
Extreme 0.1002
0.14
Current year
0.10
Extreme 0.096
0.16
1 year
0.08
Extreme 0.0804
0.20
3 years
0.08
Extreme 0.0804
6.19
5 years
0.08
Extreme 0.0804
6.19
10 years
0.08
Extreme 0.0804
14.27
More quotes

Managers and Directors - Quantum Genomics

Managers TitleAgeSince
Jean-Philippe Milon CEO
 Chief Executive Officer 63 -
Lionel Ségard FOU
 Founder 56 23/05/23
Benoît Gueugnon DFI
 Director of Finance/CFO - 01/18/01
Members of the board TitleAgeSince
Lionel Ségard FOU
 Founder 56 23/05/23
François Pelen BRD
 Director/Board Member 66 -
Jean-Philippe Milon CEO
 Chief Executive Officer 63 -
More insiders

Quotes

Date Price Change Volume
26/24/26 0.1292 +1.89% 97,834
25/24/25 0.1268 -3.94% 151,269
24/24/24 0.132 +18.07% 312,881
23/24/23 0.1118 +0.54% 13,161
22/24/22 0.1112 -5.44% 1,180

Real-time Euronext Paris, April 26, 2024 at 08:55 pm IST

More quotes

Company Profile

Quantum Genomics is a biotechnology company that specializes in the research and development of drugs for the treatment of cardiovascular diseases such as high blood pressure and heart failure. All sales are abroad.
Sector
Biotechnology & Medical Research
More about the company

Income Statement Evolution

More financial data

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
SELL
Number of Analysts
1
Last Close Price
0.1292 EUR
Average target price
0.1 EUR
Spread / Average Target
-22.60%
Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Other Biotechnology & Medical Research

1st Jan change Capi.
QUANTUM GENOMICS Stock Quantum Genomics
+21.89% 4.81M
IQVIA HOLDINGS INC. Stock Iqvia Holdings Inc.
+1.51% 42.75B
LONZA GROUP AG Stock Lonza Group AG
+49.22% 41.61B
MODERNA, INC. Stock Moderna, Inc.
+8.57% 41.34B
CELLTRION, INC. Stock Celltrion, Inc.
-12.36% 26.59B
ICON PUBLIC LIMITED COMPANY Stock ICON Public Limited Company
+8.92% 25.49B
ALNYLAM PHARMACEUTICALS, INC. Stock Alnylam Pharmaceuticals, Inc.
-25.13% 18.12B
MEDPACE HOLDINGS, INC. Stock Medpace Holdings, Inc.
+29.17% 12.24B
CHARLES RIVER LABORATORIES INTERNATIONAL, INC. Stock Charles River Laboratories International, Inc.
-3.12% 11.76B
UNITED THERAPEUTICS CORPORATION Stock United Therapeutics Corporation
+6.35% 11B
Other Biotechnology & Medical Research
  1. Stock Market
  2. Equities
  3. ALQGC Stock